A.M. Vitals: FDA Panel Votes to Strip Avastin’s Breast Cancer Indication


Published On: July 21st, 2010

Also: Harvard Med School tightens its rules on faculty-industry involvement; WellPoint exec leaves; Chamber of Commerce sets up health-overhaul complaint site.

Here is the original post:
A.M. Vitals: FDA Panel Votes to Strip Avastin’s Breast Cancer Indication



Loading...


Comments are closed.